ASP Isotopes

ASP Isotopes EBIT Margin

The EBIT Margin (Operating Margin) of ASP Isotopes (ASPI) as of Nov 18, 2026 is -239.80 %. In the previous year, EBIT Margin (Operating Margin) was -635.96 % — a change of -62.29% (higher).

EBIT Margin

-239.80 %

YoY

-62.29%

Last updated:

EBIT Margin (Operating Margin) of ASP Isotopes is 2025 -239.80 % . EBIT Margin (Operating Margin) of ASP Isotopes was 2024 -635.96 % . It decreases by -62.29% higher compared to the previous year.

For ASP Isotopes, the operating (EBIT) margin of -239.8% is down versus -45.3% a few years ago.

The ASP Isotopes EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
-45.33 USD
Jan 1, 2023
-3,704.63 USD
Jan 1, 2024
-635.96 USD
Jan 1, 2025
-239.80 USD
The ASP Isotopes EBIT Margin history
YEAREBIT MarginYoY
-239.80 %-62.29%
-635.96 %-82.83%
-3,704.63 %+8,072.50%
-45.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ASP Isotopes Stock analysis

What does ASP Isotopes do? ASP Isotopes, Inc. generates revenue through the development and commercialization of enriched isotopes using its Aerodynamic Separation Process (ASP technology). The company focuses on producing Carbon-14 (C-14), Molybdenum-100 (Mo-100), and Silicon-28 (Si-28) for specialized markets, with plans to expand into Uranium-235 (U-235) for the nuclear energy sector. Its subsidiaries, ASP Isotopes Guernsey Limited and Enriched Energy LLC, handle high-value isotope production and uranium development, respectively. The company licenses ASP technology from Klydon Proprietary Ltd for all isotope-related activities. The target customers for C-14, Mo-100, and Si-28 are highly specialized end markets requiring low-volume, high-value isotopes. Enriched Energy LLC specifically targets the nuclear energy market with uranium products. ASP Isotopes Guernsey Limited focuses on niche applications where isotope enrichment is critical, such as medical and industrial uses. The company’s revenue model relies on the sale of these enriched isotope products to specialized industries rather than mass-market consumers. ASP Isotopes, Inc. operates under a pre-commercial stage, meaning it is still developing its production capabilities and has not yet achieved full-scale commercialization. The company’s initial revenue streams will come from the sale of C-14, Mo-100, and Si-28, with future expansion into U-235 expected to diversify its product portfolio. The Aerodynamic Separation Process (ASP technology) is central to its business model, enabling the enrichment of natural isotopes into higher concentration products for specialized applications. ASP Isotopes is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ASP Isotopes stock

EBIT Margin (Operating Margin) of ASP Isotopes is -239.80 % in 2025.

EBIT Margin (Operating Margin) of ASP Isotopes changed from -635.96 % to -239.80 %, representing a -62.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) ASP Isotopes since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s ASP Isotopes with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — ASP Isotopes

All Key Metrics — ASP Isotopes